FOEHR MATTHEW W — SEC Form 4 filings
SEC reporting owner CIK 1237556. 20 Form 4 filings on record with FilingPulse; latest filed 2026-04-07.
Transaction summary — filings shown
Covers all 20 filings on record, filed 2024-02-20 to 2026-04-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 465,000 shares, $2,227,590 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 10 legs across 9 filings — 208,820 shares, $1,058,750 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 53.
- Largest priced transaction: purchase of 225,000 shares @ $5.19 ($1,167,750) in OmniAb, Inc., filed 2024-03-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| OmniAb, Inc. (OABI) | President and CEO, Director | 17 | 2 legs · 465,000 sh · $2,227,590 | 9 legs · 192,820 sh · $497,056 | 46 |
| Viking Therapeutics, Inc. (VKTX) | Director | 3 | — | 1 leg · 16,000 sh · $561,694 | 7 |
Form 4 filings — FOEHR MATTHEW W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-07 | 4 | OmniAb, Inc. (OABI) | Option exercise (M): 36,459 @ $0 · Sale (S): 19,244 @ $1.49 · Option exercise (M): 36,459 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | OmniAb, Inc. (OABI) | Option exercise (M): 58,333 · Sale (S): 30,843 @ $1.71 · Option exercise (M): 58,333 (derivative) @ $0 · Grant/award (A): 156,250 (derivative) @ $0 · Grant/award (A): 1,562,500 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | OmniAb, Inc. (OABI) | Option exercise (M): 36,458 @ $0 · Sale (S): 20,754 @ $1.70 · Option exercise (M): 36,458 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Viking Therapeutics, Inc. (VKTX) | Option exercise (M): 16,000 @ $3.33 · Sale (S): 16,000 @ $35.11 · Grant/award (A): 3,150 @ $0 · Option exercise (M): 16,000 (derivative) @ $0 · Grant/award (A): 20,400 (derivative) @ $0 | EDGAR |
| 2025-12-09 | 4 | OmniAb, Inc. (OABI) | Option exercise (M): 26,554 @ $0 · Sale (S): 13,666 @ $1.96 · Option exercise (M): 26,554 (derivative) @ $0 | EDGAR |
| 2025-08-26 | 4 | OmniAb, Inc. (OABI) | Grant/award (A): 540,540 @ $1.85 | EDGAR |
| 2025-04-14 | 4 | Viking Therapeutics, Inc. (VKTX) | Option exercise (M): 20,786 @ $8 · Option exercise (M): 20,786 (derivative) @ $0 | EDGAR |
| 2025-04-07 | 4 | OmniAb, Inc. (OABI) | Option exercise (M): 36,458 @ $0 · Sale (S): 19,382 @ $2 · Option exercise (M): 36,458 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | OmniAb, Inc. (OABI) | Option exercise (M): 26,549 · Option exercise (M): 36,458 · Sale (S): 13,964 @ $3.68 · Sale (S): 19,522 @ $3.67 · Option exercise (M): 26,549 (derivative) @ $0 · Option exercise (M): 36,458 (derivative) @ $0 · +2 more | EDGAR |
| 2025-01-22 | 4 | OmniAb, Inc. (OABI) | Grant/award (A): 77,003 @ $0 · Sale (S): 41,811 @ $3.24 | EDGAR |
| 2025-01-06 | 4 | Viking Therapeutics, Inc. (VKTX) | Grant/award (A): 18,800 (derivative) @ $0 | EDGAR |
| 2024-12-10 | 4 | OmniAb, Inc. (OABI) | Option exercise (M): 26,555 · Sale (S): 13,634 @ $4.13 · Option exercise (M): 26,555 (derivative) @ $0 | EDGAR |
| 2024-11-26 | 4 | OmniAb, Inc. (OABI) | Option exercise (M): 31,074 @ $3.68 · Option exercise (M): 68,360 @ $3.75 · Option exercise (M): 31,074 (derivative) @ $0 · Option exercise (M): 68,360 (derivative) @ $0 | EDGAR |
| 2024-06-27 | 4 | OmniAb, Inc. (OABI) | Option exercise (M): 18,644 @ $3.68 · Option exercise (M): 41,015 @ $3.75 · Option exercise (M): 18,644 (derivative) @ $0 · Option exercise (M): 41,015 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | OmniAb, Inc. (OABI) | Purchase (P): 240,000 @ $4.42 | EDGAR |
| 2024-04-23 | 4/A | OmniAb, Inc. (OABI) | Grant/award (A): 1,431,618 | EDGAR |
| 2024-04-09 | 4 | OmniAb, Inc. (OABI) | Option exercise (M): 36,458 · Tax withholding (F): 18,477 @ $5.31 · Option exercise (M): 36,458 (derivative) @ $0 | EDGAR |
| 2024-03-29 | 4 | OmniAb, Inc. (OABI) | Option exercise (M): 93,222 @ $3.68 · Option exercise (M): 150,391 @ $3.75 · Option exercise (M): 93,222 (derivative) @ $0 · Option exercise (M): 150,391 (derivative) @ $0 | EDGAR |
| 2024-03-25 | 4 | OmniAb, Inc. (OABI) | Purchase (P): 225,000 @ $5.19 | EDGAR |
| 2024-02-20 | 4 | OmniAb, Inc. (OABI) | Option exercise (M): 10,770 · Tax withholding (F): 5,459 @ $5.54 · Option exercise (M): 26,558 · Tax withholding (F): 13,460 @ $5.54 · Option exercise (M): 10,770 (derivative) @ $0 · Option exercise (M): 26,558 (derivative) @ $0 · +2 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1237556 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →